293 related articles for article (PubMed ID: 30785927)
1. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA
PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927
[TBL] [Abstract][Full Text] [Related]
2. Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction.
Honorio P; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2022 Dec; 368():110227. PubMed ID: 36302488
[TBL] [Abstract][Full Text] [Related]
3. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
5. Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations.
Honorio P; Sainimnuan S; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2021 Aug; 344():109523. PubMed ID: 34033838
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
[TBL] [Abstract][Full Text] [Related]
7. Binding interactions and in silico ADME prediction of isoconessimine derivatives as potent acetylcholinesterase inhibitors.
Tue-Ngeun P; Rakitikul W; Thinkumrob N; Hannongbua S; Meelua W; Jitonnom J
J Mol Graph Model; 2024 Jun; 129():108746. PubMed ID: 38401250
[TBL] [Abstract][Full Text] [Related]
8. Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.
Sahin Z; Ertas M; Bender C; Bülbül EF; Berk B; Biltekin SN; Yurttaş L; Demirayak Ş
Drug Dev Res; 2018 Dec; 79(8):406-425. PubMed ID: 30343499
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
Koly HK; Sutradhar K; Rahman MS
J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
[TBL] [Abstract][Full Text] [Related]
10. Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer's disease.
Eslami M; Nezafat N; Negahdaripour M; Ghasemi Y
J Biomol Struct Dyn; 2019 Nov; 37(18):4825-4839. PubMed ID: 30689517
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
12. Understanding binding between donepezil and human ferritin: molecular docking and molecular dynamics simulation approach.
Shahwan M; Khan MS; Husain FM; Shamsi A
J Biomol Struct Dyn; 2022 Jun; 40(9):3871-3879. PubMed ID: 33228460
[TBL] [Abstract][Full Text] [Related]
13. Design of vilazodone-donepezil chimeric derivatives as acetylcholinesterase inhibitors by QSAR, molecular docking and molecular dynamics simulations.
Guo L; Chang Z; Tong J; Gao P; Zhang Y; Liu Y; Yang Y; Wang C
Phys Chem Chem Phys; 2024 Jul; 26(26):18149-18161. PubMed ID: 38896464
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
[TBL] [Abstract][Full Text] [Related]
15. Oxime-dipeptides as anticholinesterase, reactivator of phosphonylated-serine of AChE catalytic triad: probing the mechanistic insight by MM-GBSA, dynamics simulations and DFT analysis.
Chadha N; Tiwari AK; Kumar V; Lal S; Milton MD; Mishra AK
J Biomol Struct Dyn; 2015; 33(5):978-90. PubMed ID: 24805972
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors.
Green KD; Fosso MY; Garneau-Tsodikova S
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544832
[TBL] [Abstract][Full Text] [Related]
17. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
Ghosh S; Jana K; Ganguly B
Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
[TBL] [Abstract][Full Text] [Related]
18. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
[TBL] [Abstract][Full Text] [Related]
19. Computational studies of acetylcholinesterase complexed with fullerene derivatives: a new insight for Alzheimer disease treatment.
da Silva Gonçalves A; França TC; Vital de Oliveira O
J Biomol Struct Dyn; 2016 Jun; 34(6):1307-16. PubMed ID: 26219766
[TBL] [Abstract][Full Text] [Related]
20. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
